Q2 2023 Marinomed Biotech AG Earnings Call Transcript
On behalf of Montego, a warm welcome to today's earnings call of Marinomed Biotech AG. Following the publication of the company's half-year figures for 2023, the CEO, Andreas Grassauer; and the CFO, Pascal Schmidt, will give you a presentation on the results in a moment, and the floor will be opened for upcoming questions following the presentation. Having said that, the stage is yours.
Thank you very much, and welcome, everybody, to our half-year earnings call. And we'll jump right into the presentation. Next to me is Pascal Schmidt, our CFO, and also warm welcome to Pascal. We'll talk today, of course, about the highlights of the year to date. Then Pascal will do a dive into the financial of the first half. Then I will take it back, talk about the growth strategy and the project outlook, how we're going to see the rest of the year, and what the progress of the important projects, and at the end, we'll briefly talk about the financial calendar.
Yeah. What have we seen in the first half of 2023? First of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
